HOME >> BIOLOGY >> NEWS
Prediction models help identify increased risk of gene mutation linked with colorectal cancer

eptember 27 issue of JAMA.

Sining Chen, Ph.D., of the Johns Hopkins Bloomberg School of Public Health, Baltimore, and colleagues conducted a study to develop a genetic counseling and risk prediction tool to estimate the probability of carrying a mutation in mismatch repair (MMR; a system within the cell for correcting errors in DNA) genes MLH1, MSH2, or MSH6, and the probability of developing colorectal or endometrial cancer. The researchers developed MMRpro, a model that estimates probability based on family history of colorectal and endometrial cancer. External validation of the MMRpro model was conducted on 279 individuals from 226 clinic-based families in the United States, Canada, and Australia (between 1993-2005). All individuals were screened extensively for MLH1 and MSH2 mutations.

"MMRpro predicted the presence of approximately 129 mutations. This shows a close correspondence (calibration) with the observed 121 mutations (ratio of observed to expected results, 0.94)," the authors write. "This results in higher accuracy than existing alternatives and current clinical guidelines."

"This article introduces MMRpro, a model for prediction of genetic susceptibility in the Lynch syndrome, which makes efficient use of family history and tumor information and provides individualized evaluations. Because model-based prediction algorithms are increasingly used in genetic counseling and prevention activities, MMRpro is a timely tool for identifying and counseling families at risk for the Lynch syndrome and can improve current genetic counseling and early detection practice." (JAMA. 2006;296:1479-1487. Available pre-embargo to the media at www.jamamedia.org.)

Editor's Note: Please see the article for additional information, including other authors, author contributions and affiliations, financial disclosures, funding and support, etc.


Editorial: Predicting and Preventing
'"/>

Contact: Janet Haley Dubow
617-632-5665
JAMA and Archives Journals
26-Sep-2006


Page: 1 2 3 4

Related biology news :

1. Prediction of graft-versus-host disease by gene-expression profiling of donors and more
2. Prediction of a prokaryotic RNA-silencing system
3. Prediction of gene function in mammals
4. Huntingtons disease study shows animal models on target
5. Scripps research scientists show protein accelerates breast cancer progression in animal models
6. Better chemistry through living models
7. Fly and worm models to teach researchers about human biology and medicine
8. Arctic ice retreating more quickly than computer models project
9. Statin treatment improves spatial memory in mouse models of Alzheimers
10. Duke geologists book assails unrealistic mathematical models
11. Rotting leaf litter study could lead to more accurate climate models

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/17/2019)... ... 15, 2019 , ... Modality Solutions, a biopharmaceutical ... on the Houston Business Journal’s Fast 100 list. Modality Solutions ranked No. 91 ... in Houston, Modality Solutions is a biopharmaceutical cold chain engineering firm with regulatory ...
(Date:10/11/2019)... ... October 11, 2019 , ... ... surgeon, oncologist, and researcher Dr. Pavel Tyan has been appointed Therapeutic Lead for ... the organization, further enhancing the already strong scientific and delivery credentials previously offered ...
(Date:10/8/2019)... ... October 08, 2019 , ... ... that make it easier than ever for businesses and organizations to use their ... App enables organizations to count down to or count up from date-related milestones, ...
Breaking Biology News(10 mins):
(Date:10/3/2019)... ... October 01, 2019 , ... Today Cereset®, the ... the midway point of its randomized research trial for individuals with persisting symptoms ... the efficacy of a non-invasive technology which compares tones delivered to a subject’s ...
(Date:10/3/2019)... ... October 02, 2019 , ... ... is pleased to announce that it has moved into a new, 5000 sqft, ... instruments, the new facility demonstrates the company's continuous commitment to quality research and ...
(Date:9/24/2019)... Mass. (PRWEB) , ... September ... ... global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, ... NERV), a clinical-stage biopharmaceutical company focused on the development of therapies to ...
(Date:9/17/2019)... ... September 17, 2019 , ... Catalent, a ... and Clinical Supplies Management, Asia Pacific (APAC) will present at the upcoming 3rd ... Sept. 25-26, 2019. , On Thursday, Sept. 26, at 10:10 a.m., Ms. Delaney ...
Breaking Biology Technology:
Cached News: